Aerosol inhaled MVA85A

BIOLOGICAL2 trials

Sponsors

University of Oxford

Conditions

Tuberculosis

Phase 1

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

CompletedNCT01497769

University of OxfordTuberculosis

Start: 2011-09-30End: 2013-04-30Updated: 2013-07-02

MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection

TerminatedNCT02532036

University of OxfordTuberculosis

Start: 2015-09-30End: 2018-10-04Updated: 2020-08-31

Related Papers

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults

Vaccines2021-04-1615 citations

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial

PLoS Medicine2019-04-3066 citations

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.

2014-08-20137 citations